IDRA - Idera Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5108.18M
Enterprise Value 396.94M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)146.99
Price/Book (mrq)1.44
Enterprise Value/Revenue 3131.71
Enterprise Value/EBITDA 6-1.65

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018


Profit Margin 0.00%
Operating Margin (ttm)-8,045.92%

Management Effectiveness

Return on Assets (ttm)-47.46%
Return on Equity (ttm)-91.51%

Income Statement

Revenue (ttm)736k
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)-11.60%
Gross Profit (ttm)-18.52M
EBITDA -58.64M
Net Income Avi to Common (ttm)-62.66M
Diluted EPS (ttm)-2.46
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)82.46M
Total Cash Per Share (mrq)3.03
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)8.25
Book Value Per Share (mrq)2.76

Cash Flow Statement

Operating Cash Flow (ttm)-51.94M
Levered Free Cash Flow (ttm)-26.58M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.28
52-Week Change 3-57.03%
S&P500 52-Week Change 3-1.47%
52 Week High 320.40
52 Week Low 33.89
50-Day Moving Average 37.03
200-Day Moving Average 38.93

Share Statistics

Avg Vol (3 month) 3239.09k
Avg Vol (10 day) 3229.54k
Shares Outstanding 527.18M
Float 19.43M
% Held by Insiders 120.14%
% Held by Institutions 144.44%
Shares Short (Nov 30, 2018) 4358.73k
Short Ratio (Nov 30, 2018) 41.73
Short % of Float (Nov 30, 2018) 41.90%
Short % of Shares Outstanding (Nov 30, 2018) 41.32%
Shares Short (prior month Oct 31, 2018) 4506.11k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 28/1
Last Split Date 3Jul 30, 2018